4//SEC Filing
SATO VICKI L 4
Accession 0001714899-24-000198
CIK 0001714899other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 6:26 PM ET
Size
6.7 KB
Accession
0001714899-24-000198
Insider Transaction Report
Form 4
SATO VICKI L
Director
Transactions
- Sale
Common Stock
2024-09-03$24.99/sh−2,980$74,470→ 116,276 total - Sale
Common Stock
2024-09-03$25.37/sh−100$2,537→ 116,176 total
Footnotes (3)
- [F1]The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 21, 2024.
- [F2]The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $24.37 to $25.32 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F3]Includes 5,967 unvested RSUs.
Documents
Issuer
Denali Therapeutics Inc.
CIK 0001714899
Entity typeother
Related Parties
1- filerCIK 0001197020
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 6:26 PM ET
- Size
- 6.7 KB